Tiếng Việt
(Ngày Nay) – Viraleze antiviral nasal spray is evaluated as a safe solution to prevent epidemics, besides implementing 5K regulations.
 |
| Press conference to launch Viraleze antiviral nasal spray |
On December 4, the People’s Court Magazine in collaboration with T.A.F Medical Equipment Joint Stock Company held a press conference to announce and introduce the antiviral Viraleze nasal spray in Vietnam market.
Viraleze is a product manufactured by Starpharma Biotechnology Company, based in Australia, officially announced and circulated in Vietnam from November 30, 2021.
In the face of a complicated epidemic situation, in addition to complying with protective measures in many ways such as cleaning frequently touched surfaces, applying 5K measures and injecting vaccines, many pharmaceutical companies in the world The world has researched products to help health, prevent viruses, and provide opportunities to protect people’s safety.
In particular, the Viraleze anti-viral nasal spray product is a compact, convenient product with proven effectiveness, which will contribute to preventing disease, bringing safety to users.
This product not only provides a moisturizing protective barrier to the nasal mucosa, but can also be used to increase safety when needed.
A representative of T.A.F Company said that Viraleze antiviral spray is not a drug and is classified as a group A medical device.
According to data published by the manufacturer on June 18, 2021, the active ingredients in Viraleze nasal spray are more than 99.99% effective against viruses.
Source: Ngày Nay
